Association of TCF7L2 Gene Variants with Glycemic Control During Metformin Therapy in Type 2 Diabetes Mellitus
Objective: The transcription factor 7-like 2 (TCF7L2) gene variants are among the strongest genetic risk factors for type 2 diabetes mellitus (T2DM). However, their influence on glycemic control during metformin therapy remains incompletely understood. This study aimed to investigate variants in the TCF7L2 gene and to...